Home
Conditions
Melanoma Metastatic

Clinical trial condition

Melanoma Metastatic

Explore clinical trials studying Melanoma Metastatic. Study availability and eligibility vary by location and protocol.

17 public trials 11 recruiting studies

Refine in advanced search Browse all conditions

Melanoma Metastatic trial results

Recruiting

Tunlametinib in Combination With Pucotenlimab and Hydroxychloroquine in NRAS Mutant Melanoma

NCT07750067

Conditions: Melanoma, Melanoma Metastatic, NRAS Mutation, +11 more
Locations: Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Dietary Fiber to Induce Gut Microbiota-mediated Response to Immunotherapy in Melanoma.

NCT07686835

Conditions: Melanoma, Melanoma (Skin Cancer), Melanoma (Skin) Stage IV, +13 more
Locations: Medical Oncology Nijmegen, Gelderland, Netherlands

Universitair Medisch Centrum Groningen Groningen, Provincie Groningen, Netherlands

View Trial Details

Recruiting

A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors.

NCT06889610

Conditions: Breast Diseases, Breast Neoplasms, Colorectal Cancer Metastatic, +7 more
Locations: Fudan University Shanghai Cancer Center Shanghai, China

View Trial Details

Recruiting

NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma

NCT06889766

Conditions: Advanced Melanoma, Melanoma, Melanoma Metastatic, +13 more
Locations: Centre Hospitalier Universitaire Vaudois (CHUV) Lausanne, Canton of Vaud, Switzerland

Centre Hospitalier Universitaire Vaudois Lausanne, Canton of Vaud, Switzerland

View Trial Details

Recruiting

Stereotactic Ablative Radiotherapy (XRT) and Immunotherapy for Oligometastatic Extracranial Melanoma

NCT06767306

Conditions: Melanoma Metastatic
Locations: Westmead Hospital Westmead, New South Wales, Australia

Melanoma Institute Australia Wollstonecraft, New South Wales, Australia

Princess Alexandra Hospital Woolloongabba, Queensland, Australia

The Alfred Hospital Melbourne, Victoria, Australia

View Trial Details

Recruiting

A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma

NCT07076550

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +21 more
Locations: Alfred Health Melbourne, Victoria, Australia

Austin Health Melbourne, Victoria, Australia

Fiona Stanley Hospital Murdoch, Western Australia, Australia

GenesisCare Murdoch Murdoch, Western Australia, Australia

View Trial Details

Recruiting

Study to Evaluate Impact® as Support to Anti PD1 or Anti PD1 Based Regimen Treatment in Patients With Inoperable Locally Advanced or Metastatic Melanoma

NCT06880198

Conditions: Locally Advanced Melanoma, Melanoma Metastatic
Locations: Istituto Nazionale Tumori IRCCS - Fondazione "G. Pascale" Naples, Italy

View Trial Details

Recruiting

Anti PD-1 Plus Postbiotic Versus Anti PD-1 Alone in Locally Advanced or Metastatic, Treatment naïve, Cutaneous Melanoma Study

NCT07050940

Conditions: Melanoma, Melanoma Metastatic, Neoplasms, +10 more
Locations: Bari University-Oncologia medica Bari, BA, Italy

Torino University-Le Molinette Torino, TO, Italy

IRCCS Papa Giovanni II Bari Bari, Italy

INT Milano Milan, Italy

View Trial Details

Recruiting

Observational Study of Patients With Advanced Melanoma (Skin Cancer) to Assess if IOpener®-Melanoma Test Can Predict Response to Immunotherapy.

NCT06784778

Conditions: Melanoma, Melanoma Advanced, Melanoma Metastatic, +13 more
Locations: Universitätsklinikum Tübingen Tübingen, Baden-Wurttemberg, Germany

Heidelberg University Hospital Heidelberg, Germany

LMU Klinikum München, Germany

View Trial Details

Recruiting

T-cell Therapy with CRISPR PD1-edited Tumor Infiltrating Lymphocytes for Patients with Metastatic Melanoma

NCT06783270

Conditions: Melanoma Metastatic
Locations: CCIT-DK Herlev, Capital Region, Denmark

View Trial Details

Melanoma Metastatic

Melanoma Metastatic trial results

Related conditions